Drug treatments proven to be effective for SMA
Nusinersen was developed by Ionis pharamaceutical company. On 23rd December 2016, it was licensed and marketed in the USA as Spinraza by Biogen pharmaceutical company.
What Happens After a Successful Clinical Trial
Dr. Alex Murphy describes the processes that have to be gone through before a drug can be prescribed for an individual in the UK.
Find out what stage other drugs have reached in our: